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Negative Regulation of PKB/Akt-Dependent
Cell Survival by the Tumor Suppressor PTEN
The PTEN gene encodes a 403-amino-acid polypep-
tide with a high degree of homology to protein tyrosine
phosphatases and tensin (Li et al., 1997; Steck et al.,
Vuk Stambolic,*²§ Akira Suzuki,*²§
JoseÂ Lois de la Pompa,*² Greg M. Brothers,*²
Christine Mirtsos,*² Takehiko Sasaki,*²
1997). PTEN is capable of dephosphorylating both phos-Jurgen Ruland,*² Josef M. Penninger,*²
pho-tyrosine and phospho-serine/threonine-containingDavid P. Siderovski,*² and Tak W. Mak*²³
synthetic substrates in vitro (Myers et al., 1997). Re-*Amgen Institute
cent evidence also demonstrates the ability of PTEN620 University Avenue
to dephosphorylate position D3 of phosphatidylinositolToronto, Ontario
(3,4,5) trisphosphate, a direct product of phosphatidyl-²Ontario Cancer Institute and Departments
inositol 39 kinase (PI39K) activity (Maehama and Dixon,of Medical Biophysics and Immunology
1998). The importance of an intact PTEN phosphataseUniversity of Toronto
domain for its tumor suppressor function is underscoredToronto, Ontario
by findings that a large proportion of tumor-associatedCanada M5G 2C1
PTEN mutations map to the region encoding the phos-
phatase domain (Rasheed et al., 1997; Marsh et al.,
1998). Furthermore, unlike wild-type PTEN, catalytically
Summary inactive PTEN is unable to suppress growth and tumori-
genicity of PTEN-deficient glioblastoma cells (Furnari et
PTEN is a tumor suppressor with sequence homology al., 1997).
to protein tyrosine phosphatases and the cytoskeletal The N-terminal domain of PTEN shows extensive ho-
mology to tensin, a protein associated with the actinprotein tensin. mPTEN-mutant mouse embryos dis-
cytoskeleton at focal adhesions (Lo et al., 1994). Recentplay regions of increased proliferation. In contrast,
evidence demonstrates that overexpressed PTEN inter-mPTEN-deficient immortalized mouse embryonic fi-
acts directly with focal adhesion kinase (FAK) and re-broblasts exhibit decreased sensitivity to cell death in
duces its tyrosine phospholylation. In addition, PTENresponse to a number of apoptotic stimuli, accompa-
was shown to inhibit cell migration, integrin-mediatednied by constitutively elevated activity and phosphory-
cell spreading, and formation of focal adhesions (Ta-lation of protein kinase B/Akt, a crucial regulator of
mura et al., 1998). Thus, both genetic and biochemicalcell survival. Expression of exogenous PTEN in mutant
evidence has implicated PTEN in the regulation of sev-cells restores both their sensitivity to agonist-induced
eral different cellular processes: cell growth, extracellu-apoptosis and normal pattern of PKB/Akt phosphory-
lar matrix interactions, and/or cell migration.lation. Furthermore, PTEN negatively regulates intra-
To determine the role of the PTEN in normal develop-cellular levels of phosphatidylinositol (3,4,5) trisphos-
ment and tumorigenesis, we have generated mPTEN-phate in cells and dephosphorylates it in vitro. Our
deficient mice by targeted disruption of exon 3 to 5.results show that PTEN may exert its role as a tumor
Homozygous mPTEN3-5 mutant mice die by day 9.5 ofsuppressor by negatively regulating the PI39K/PKB/
development and show abnormal patterning and over-Akt signaling pathway.
growth of the cephalic and caudal regions (A. S. et al.,
submitted). Analysis of mPTEN3-5 embryos reveals re-
gions of increased proliferation. In contrast, immortalizedIntroduction
mouse embryonic fibroblast cell lines from mPTEN3-5
homozygous mutant embryos show decreased sensitiv-
Loss of heterozygosity on human chromosome 10 is the
ity to various apoptotic stimuli, including UV irradiation,
most common genetic alteration in the development of heat shock, osmotic stress, and tumor necrosis factor
malignant gliomas (Bigner et al., 1998). Recent identifi-
a stimulation. mPTEN mutant cells display constitutively
cation of PTEN (also known as MMAC1 and TEP1) (Li elevated activity of PKB/Akt, which can be restored to
and Sun, 1997; Li et al., 1997; Steck et al., 1997) as the normal levels by reexpression of mPTEN. Consistent
candidate tumor suppressor gene located on chromo- with these findings, an active mutant of PKB/Akt sup-
some 10 initiated a number of studies that have demon- presses apoptosis induced by mPTEN overexpression.
strated a significant rate of mutations of the PTEN gene Our results demonstrate that PTEN negatively regulates
not only in gliomas (Rasheed et al, 1997) but also in intracellular levels of PI(3,4,5)P3, most likely via direct
endometrial (Tashiro et al., 1997), prostate (Cairns et al., dephosphorylation, providing a mechanism for PTEN
1997), and breast cancers (Rhei et al., 1997). In addition action. We propose that PTEN exerts its role as a tumor
to frequent mutations in sporadic tumors, germline mu- suppressor by negatively regulating the PI93K/PKB/Akt
tations of PTEN are believed to cause Cowden disease signaling pathway.
(Liaw et al., 1997), an autosomal-dominant hamartoma
syndrome, which results in increased risk for the devel- Results
opment of breast, thyroid, and brain tumors (Eng, 1998).
Enhanced Proliferation in E8.5 mPTEN3-5
Mutant Embryos³ To whom correspondence should be addressed (e-mail: tmak@
mPTEN-deficient mice were generated by targeted dis-oci.utoronto.ca)
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Figure 1. Extensive Proliferation of mPTEN3-5
Mutant Embryos In Vitro and In Vivo
(A) Wild-type blastocyst outgrowth after 10
days of culture. The inner cell mass (ICM) has
grown extensively and remains coherent.
(B) mPTEN3-5 mutant blastocyst showing a
large ICM that spreads out in the dish.
(C) E7.5 wild-type embryo. Strongly BrdU-
positive cells can be seen throughout all em-
bryonic regions. al, allantois; ch, chorion; ee,
embryonic ectoderm; m, mesoderm.
(D) E7.5 mPTEN3-5 mutant embryo showing
strong BrdU incorporation and a very thick
ectoderm region (arrow).
(E) Cross section through the headfold region
of a E8.5 wild-type embryo, showing BrdU
staining in the neuroepithelium (arrowhead)
and underlying mesenchyme (mes).
(F) Cross section of the headfold of a mPTEN3-5
mutant embryo. Very strong staining can be
seen in the neuroepithelium (arrowhead) and
underlying mesenchyme. Bar, 40 mm in (A)
and (B); 140 mm in (C)±(F).
gous mPTEN3-5 mutant mice die by day 9.5 of develop- type embryos showed extensive BrdU labeling, particu-
larly in the ectoderm region (Figure 1C). A total of threement (E9.5), and, at E8.5, a typical phenotypic feature
of the mutants is dramatic overgrowth in the cephalic wild-type embryos were analyzed, and they showed a
proliferative index of 0.7 6 0.1. mPTEN3-5 mutant em-and caudal regions (A. S. et al., submitted), suggesting
a possible defect in programmed cell death or cellular bryos appear more primitive and show very strong BrdU
staining in all germ layers (Figure 1D). Three mutantproliferation. Apoptosis, as measured by TUNEL assay
(Gavrieli et al., 1992) or DAPI staining, showed no obvi- embryos analyzed gave an index of 0.8 6 0.1. At E8.5,
the differences in proliferation between wild-type andous differences between wild-type and mutant embryos
(data not shown). mutant embryos were apparent. Figure 1E shows BrdU
staining in the cephalic region of a E8.5 wild-type em-Next, we analyzed the proliferative capacity of mPTEN3-5
mutant embryos in vitro and in vivo. E3.5 blastocysts bryo. BrdU-positive cells appear scattered throughout
the neuroepithelium of the head folds and underlyingcultured in vitro organize into a compact inner cell mass
and a surrounding trophoblast (Figure 1A). mPTEN3-5 cephalic mesenchyme. Three wild-type embryos were
analyzed at E8.5, and they gave a proliferative index ofmutant blastocysts grow similarly to wild-type litter-
mates for a period of up to 10 days, although they tend 0.7 6 0.05. In contrast, mPTEN3-5 mutant embryos show
BrdU staining throughout the deformed head folds andto appear more expanded and disorganized relative to
normal littermates (Figure 1B). To measure directly the in the cephalic mesenchyme that is significantly stronger
than in wild-type embryos (Figure 1F). Three mutanteffects of the mPTEN3-5 mutation on cellular proliferation,
we examined the incorporation of 5-bromo-29-deoxyuri- embryos analyzed gave an index of 0.9 6 0.03. These
values were statistically significantly different (p , 0.05,dine (BrdU) into DNA during the S phase of the cell cycle.
Analysis was performed at E7.5 and E8.5, at times when Student's t test). Thus, BrdU incorporation is quantita-
tively increased in mutant embryos, suggesting that en-the mitotic activity in the mouse embryo undergoing
organogenesis is high (Snow, 1977). A proliferative index hanced proliferation is involved in the abnormal devel-
opment of the cephalic region of mPTEN3-5 mutantbased on the ratio of proliferating cells (BrdU-positive
nuclei) to total cell number was calculated. Wild-type embryos. Similarly, increased BrdU incorporation was
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Surprisingly, we observed no significant difference in
the rate of proliferation between the mPTEN homo- and
heterozygous cells (data not shown). We next examined
the rate of agonist-induced cell death in heterozygous
and mPTEN-deficient cells. As measured by viability dye
staining, more than 80% of mPTEN2/21 and mPTEN2/22
cells were viable 24 hr following treatment with UV irradi-
ation (780 J/m2), sorbitol (0.4 mM), TNFa (10 ng/ml)/
cycloheximide (5 mg/ml), anisomycin (10 mg/ml), or 30
min of heat shock at 42.58C (Figure 3A). In contrast,
these same treatments resulted in extensive cell death
in mPTEN1/2 cells. Strikingly, even 1 day after a 2 hr
heat shock, almost 40% of mPTEN2/2 cells were still
viable (Figure 3A). Similar results were obtained using
early and late markers of programmed cell death,
annexin V, and propidium iodide, respectively, sug-
gesting that the mPTEN1/2 cells were dying from apo-
ptosis (data not shown). To further test this possibility,
8 hr after treatment, nuclear morphology of mPTEN1/2
and mPTEN2/2 cells was examined. Nuclei of mPTEN1/2
cells display chromatin condensation indicative of apo-
ptosis, whereas nuclei of mPTEN2/2 appear normal
(Figure 3B). Prolonged monitoring of mPTEN2/2 cells
indicates that they eventually die in response to UV
irradiation and sorbitol treatment (Figure 3C), as well
Figure 2. Characterization of Immortalized Mouse Embryonic Fibro- as other apoptotic stimuli (data not shown), although
blasts from mPTEN Mutant Mice at a significantly reduced rate in comparison to the
(A) Western blot analysis of whole-cell lysates from brain, thymus, mPTEN1/2 cells. A similar decrease in sensitivity to apo-
and mPTEN1/2 and mPTEN2/2 cell lines. The positions of molecular ptosis was observed in mPTEN-deficient ES cells (data
weight markers (kDa) are shown on the left. The position of PTEN
not shown). Thus, reduced sensitivity of mPTEN-nega-is indicated by an arrow.
tive cells to apoptosis suggests that PTEN might exert(B) RT-PCR analysis of mPTEN1/2 and mPTEN2/2 cell lines. FSP1
its function as a tumor suppressor by negatively regulat-indicates the reactions performed using fibroblast-specific protein
1±specific primers. b2M indicates the reactions performed using b2- ing cell survival.
microglobulin-specific primers. H2O, water control (no RNA); spleen,
total RNA from normal mouse splenocytes; mPTEN1/2, total RNA
Expression of Exogenous mPTEN infrom mPTEN1/2 cells; mPTEN2/21, total RNA from mPTEN2/21 cells;
mPTEN2/22, total RNA from mPTEN2/22 cells. mPTEN-Deficient Cells Restores
Sensitivity to Apoptosis
To further investigate whether resistance to apoptosisobserved in the allantois at the posterior end of the
in mPTEN2/2 cells was a result of the loss of PTENembryo (data not shown).
function, mPTEN was expressed in all three cell lines
using recombinant retrovirus carrying an HA-taggedmPTEN-Deficient Mouse Embryonic Fibroblasts
Exhibit Decreased Sensitivity to Apoptosis copy of wild-type mPTEN, or green fluorescence protein
To further investigate the role of PTEN in regulation of (GFP) as a control. As measured by fluorescence of
cellular processes, immortalized mouse embryonic fibro- control cells, the efficency of retroviral infection was
blast cell lines from two mPTEN3-5 homozygous mutant higher than 70% in all three cell lines (data not shown).
embryos (mPTEN2/21 and mPTEN2/22, respectively) In contrast to GFP, expression of mPTEN in mPTEN-
and one heterozygous mutant embryo (mPTEN1/2) were deficient cell lines restored normal apoptosis in re-
generated. Reverse transcription±polymerase chain re- sponse to all stimuli tested (Figure 4). Retrovirus-medi-
action (RT-PCR) using RNA from generated cells shows ated expression of mPTEN in mouse NIH 3T3 cells also
the expression of fibroblast-specific protein 1 (FSP1) increased their sensitivity to cell death (data not shown),
(Strutz et al., 1995) in all three cell lines, demonstrat- confirming the role of PTEN as a negative regulator of
ing that the generated cells are fibroblasts (Figure 2). cell survival.
Immunoblotting of cell lysates from the established
cell lines confirmed the loss of mPTEN expression in
Increased Activity of Cell Survival Kinaseboth mPTEN2/21 and mPTEN2/22 cell lines, whereas
PKB/Akt in PTEN Mutant CellsmPTEN1/2 expressed a protein of the molecular mass of
One of the key regulatory molecules involved in theapproximately 55 kDa (Figure 2). The apparent molecular
regulation of cell survival is protein kinase B/Akt (PKB/mass of mPTEN is consistent with a major immunoreac-
Akt). PKB/Akt is implicated in protection from apoptosistive species identified in brain, thymus, and NIH3T3 cells
in response to several growth factors and cytokines, and(Figure 2) and of recombinant mPTEN (data not shown).
it protects cells from apoptosis induced by withdrawal ofBoth mPTEN2/2 cell lines showed no morphological dif-
survival signals, c-Myc overexpression (Kauffmann-Zehferences in comparison to their heterozygous counter-
part (data not shown). et al., 1997), or matrix detachment (Khwaja et al., 1997;
Cell
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Figure 4. Expression of PTEN Restores Susceptibility of PTEN-Defi-
cient Cells to Agonist-Induced Apoptosis
Two days following infection with retroviruses carrying PTEN
(hatched bars) or GFP (open bars), cells were treated as indicated
and analyzed for viability as in Figure 3. Viability is expressed nor-
malized to the untreated control (5% FCS). Solid bars correspond
to noninfected cells. The individual cell lines and cell treatments,
respectively, are indicated at the bottom. The presented data are
from at least three independent experiments. Error bars represent
standard error of the mean expressed in percentage.
(Alessi et al., 1997; Stokoe et al., 1997). Using an anti-
body specific for PKB/Akt phosphorylated at Ser-473
and kinase assays of immunoprecipitated PKB/Akt pro-
teins, we tested the phosphorylation status and activity
of PKB/Akt in our cells (Figure 5A). Under resting (5%
FCS) or serum-starvation (0.5% FCS) conditions, the
levels of PKB phosphorylation were elevated in both
mPTEN2/2 cell lines in comparison to mPTEN1/2 cells.
Hyperphosphorylation of PKB/Akt was accompanied by
increased activity of PKB/Akt toward a previously char-
acterized PKB/Akt-specific peptide substrate (Cross et
Figure 3. PTEN-Deficient Cells Show Decreased Sensitivity to Apo- al., 1995) (Figure 5A). Stimulation of serum-starved cells
ptosis with platelet-derived growth factor (PDGF) (50 ng/ml)
(A) PTEN-deficient cells are resistant to apoptosis. Twenty-four resulted in similar increase in phosphorylation and activ-
hours after the indicated treatment. UV, UV irradiation (780 J/m2); ity of PKB/Akt in all three cell lines, demonstrating that
TNFa, TNFa (10 ng/ml)/cycloheximide (5 mg/ml); Aniso, anisomycin
the pathway leading to PKB/Akt activation was intact(10 mg/ml); sorbitol (400 mM); heat 30', 30 min at 42.58C; heat 120',
in mPTEN2/2 cells. In addition, basal activity and PDGF-120 min at 42.58C; viable cells were determined by negative staining
induced activation of mitogen-activated protein kinaseswith 7-amino-actinomycin D (7-A-AD). Viability is expressed normal-
ized to the untreated control (5% FCS). Solid bars correspond to Erk1 and Erk2 appeared normal in all three cell lines
mPTEN1/2; open bars correspond to mPTEN2/21; gray bars corre- (data not shown). Pretreatment of serum-starved cells
spond to mPTEN2/22. The presented data are from at least four with the specific inhibitor of PI39K, wortmannin (Figure
independent experiments. Error bars represent standard error of
5A), or LY294002 (data not shown) completely elimi-the mean expressed in percentage.
nated basal as well as PDGF-dependent increase in(B) Fluorescence microscopy visualization of nuclear DAPI staining
PKB/Akt phosphorylation/activity in all cell lines. Thisof treated mPTEN1/2 and mPTEN2/2 cells. Cell line annotations are
on the left. Treatments (same as in [A]) are indicated on the top. result indicates that PI39K is responsible for both
Chromatin condensation is apparent solely in the mPTEN1/2 cell increased PKB phosphorylation/activity in nontreated
line. mPTEN2/2 cells and activation following PDGF stimula-
(C) PTEN-deficient cells show decreased sensitivity to apoptosis.
tion in all three cell lines. The reduced basal phosphory-The viability of cells treated as indicated was monitored for 3 days
lation of PKB/Akt (Figure 5B) and activity (data notas in (A). Squares correspond to mPTEN1/2; triangles correspond
shown) in mPTEN2/2 cells could be restored by retroviralto mPTEN2/21; circles correspond to mPTEN2/22. The presented
data are from at least three independent experiments. Error bars expression of mPTEN in these cells, demonstrating a
represent standard error of the mean expressed in percentage. functional interaction between mPTEN and PKB/Akt and
an active role of mPTEN in negative regulation of PKB/
Akt phosphorylation and activity. In support of such a
role is the observation of PKB/Akt hyperphosphorylation
reviewed in Downward, 1998). Furthermore, loss of PKB/ in T cell lymphomas that frequently develop in mPTEN
Akt function in Drosophila results in ectopic cell death heterozygous mice and are associated with the loss of
(Staveley et al., 1998). Phosphorylation of PKB/Akt on heterozygocity at the mPTEN locus (A. S. et al., sub-
mitted).Thr-308 and Ser-473 is required for its full activation
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Figure 6. PTEN and PKB/Akt Act in the Same Signaling Pathway
NIH 3T3 cells were transfected with constructs expressing the indi-
cated proteins (bottom) in the presence of tracer amounts of a
b-gal construct. PKB/Akt alleles are as follows: wt, wild-type; AAA,
alanine-substituted dominant-negative mutant; DD, aspartate-sub-
stituted constitutively active mutant; gag, gag-PKB/Akt fusion pro-
tein (see text for details). Forty-eight hours posttransfection cells
were fixed and stained with X-gal. The number of surviving blue
cells was counted in ten randomly selected high-power fields under
a microscope and expressed as a percentage relative to the control
transfection. The presented data are from at least three independent
experiments. Error bars represent standard error of the mean ex-
pressed in percentage.
expression can result in cell death (Figure 6). Using a
cotransfection approach, we examined the ability of
wild-type or mutant PKB/Akt to alter mPTEN-induced
cell death in NIH 3T3 cells 48 hr after transfection. Ex-
pression of wild-type PKB/Akt had no influence on
mPTEN-mediated cell death (Figure 6). However, coex-
pression of PKB-DD, a constitutively active PKB/Akt
mutant in which Thr-308 and Ser-473 have been
changed to aspartate to mimic phosphorylation (Welch
Figure 5. Negative Regulation of PI39K/PKB/Akt Signaling Pathway et al., 1998; Jing Jin and James R. Woodgett, personal
by PTEN
communication), with mPTEN increases the number of
(A) Increased phosphorylation and activity of PKB/Akt in PTEN-
surviving transfected cells to the levels comparable todeficient cells. (Top) Western blot analysis of cell lysates from cells
mock-transfected cells (Figure 6). Thus, expression oftreated as indicated. 0.5% FCS indicates incubation of cells in 0.5%
constitutively active PKB/Akt rescues transfected cellsFCS for 24 hr prior to treatment. PDGF indicates treatment with
PDGF (50 ng/ml) for 15 min. W indicates pretreatment of cells with from mPTEN-induced apoptosis and indicates a poten-
wortmannin (100 nM) for 20 min prior to addition of PDGF. Antibodies tial function of mPTEN upstream of PKB/Akt.
used in Western blotting are indicated on the left. Comparable re- PKB-AAA is a dominant-negative PKB/Akt mutant in
sults were obtained from at least four independent experiments.
which both phosphorylation sites and the lysine in the(Bottom) PKB kinase activity in mPTEN1/2 and mPTEN2/2 cell lines.
ATP-binding pocket have been mutated to alanine resi-PKB proteins were immunoprecipitated from cells treated as indi-
dues, respectively, resulting in a complete loss of kinasecated (see above) and analyzed for incorporation of 32PO4 into a
previously characterized peptide substrate (see Experimental Pro- activity (Meier et al., 1997; Stephens et al., 1998; Jing
cedures). The data are presented normalized to the activity of PKB/ Jin and James R. Woodgett, personal communication).
Akt from untreated (5% FCS) mPTEN1/2 cells. The presented data Expression of PKB-AAA induced apoptosis in NIH 3T3
are from at least three independent experiments. Error bars repre-
cells comparable to the levels achieved by mPTENsent standard error of the mean expressed in percentage.
transfection alone (Figure 6). Significantly, coexpression(B) Expression of PTEN reduces basal phosphorylation of PKB/Akt
of PKB-AAA and mPTEN did not result in an additivein mPTEN2/2 cells. Forty-eight hours after mock infection or infection
with the retrovirus expressing HA-PTEN, cells were treated as indi- effect on cell death (Figure 6), suggesting that PKB and
cated on top (see [A]). Antibodies used in Western blotting are mPTEN act in the same signaling pathway.
indicated on the left. Comparable results were obtained from at The role of mPTEN in PKB/Akt regulation is further
least three independent experiments.
supported by the effect of mPTEN on gag-PKB-medi-
ated cell survival. gag-PKB is the oncogenic form of
PKB/Akt that was identified as an oncogene carried byA Constitutively Active Mutant of PKB/Akt Rescues
Cells from PTEN-Induced Apoptosis AKT8, the acute transforming virus from a rodent T cell
lymphoma (AKR) (Bellacosa et al., 1991). The myristylExpression of mPTEN using transient transfection of
NIH 3T3 cells resulted in a decrease in the number of group of viral gag protein serves to bring gag-PKB fusion
protein to the cell membrane, where it becomes acti-surviving transfected cells in comparison to the mock-
transfected controls, indicating that high levels of mPTEN vated by upstream kinases (Ahmed et al., 1993; Kennedy
Cell
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et al., 1997; Alessi and Cohen 1998). In our studies,
transfection of gag-PKB into NIH 3T3 cells resulted in
an increase in the number of surviving cells, possibly due
to the ability of gag-PKB to protect from transfection-
induced death (Figure 6). However, cotransfection of
mPTEN with gag-PKB resulted in a decrease in the num-
ber of transfected cells comparable to that induced by
mPTEN alone (Figure 6). Considering that gag-PKB re-
quires phosphorylation of Thr-308 and Ser-473 for ac-
tivity (Kennedy et al., 1997), mPTEN is most likely
negatively regulating the phosphorylation of both PKB
and gag-PKB, consistent with our previous findings (Fig-
ure 6).
Phosphatidylinositol (3,4,5)P3 Is a Direct
Substrate of PTEN
The activity of PI39K under normal or PDGF-stimulation
conditions was identical in mPTEN1/2 and mPTEN2/2
cells (data not shown), suggesting that mPTEN was af-
fecting the PKB/Akt phosphorylation and activity by act-
ing downstream of PI39K. Treatment with wortmannin,
a specific inhibitor of PI39K, sensitized mPTEN2/2 cells
to UV irradiation± and sorbitol treatment±induced cell
death (Figure 7A), demonstrating that an immediate
product of PI39K activity was responsible for the altered
sensitivity of mPTEN2/2 cells to apoptosis. Furthermore,
constitutively active PKB/Akt rescues transfected cells
from mPTEN-induced apoptosis, implying a function of
mPTEN upstream of PKB/Akt.
PKB/Akt phosphorylation on both Thr-308 and Ser-
473 is directly dependent on the levels of intracellular
Figure 7. PTEN Dephosphorylates PI(3,4,5)P3phosphatidylinositol(3,4,5)P3, the key product of PI39K
(A) Wortmannin restores the sensitivity of mPTEN2/2 cells to apopto-activity (Alessi et al., 1996, 1997; M. Delcommene et al.,
sis. Twenty-four hours after the indicated treatment. W, wortmanninsubmitted). In mPTEN2/2 cells, PKB/Akt is hyperphos-
(50 nM); UV, UV irradiation (780 J/m2); sorbitol (400 mM); viable cellsphorylated under resting conditions (5% FCS) (Figure
were determined by negative staining with 7-amino-actinomycin D
5A). Under those conditions, mPTEN2/2 cells exhibit ele- (7-A-AD). Viability is expressed normalized to the untreated control
vated levels of intracellular PI(3,4,5)P3 in comparison to (5% FCS). Solid bars correspond to mPTEN1/2; open bars corre-
their heterozygous counterpart (Figure 7B), implying a spond to mPTEN2/21; hatched bars correspond to mPTEN2/22. The
presented data are from at least three independent experiments.direct role of mPTEN in dephosphorylation of PI(3,4,5)P3.
Error bars represent standard error of the mean expressed in per-Furthermore, bacterially expressed mPTEN dephos-
centage.phorylates the D3 position of PI(3,4,5)P3 in vitro (Figure (B) Lack of PTEN increases intracellular levels of PI(3,4,5)P3. Total7C). Thus, PI(3,4,5)P3 is a physiological substrate of cellular lipids were extracted from cells metabolically labeled with
PTEN. 32P-orthophosphate as described in Experimental Procedures and
resolved by ascending thin-layer chromatography together with
PI(3,4,5)P3 prepared as described in Experimental Procedures.Discussion Source of lipid preparations is indicated at the bottom. Quantifica-
tion of relative levels of PI(3,4,5)P3 is shown on the right; PI(3,4,5)P3
Role of PTEN in Proliferation content relative to total cellular lipid was normalized to the relative
amount of PI(3,4,5)P3 in mPTEN1/2 cells. Positions of the origin andmPTEN3-5 mutant embryos die by E9.5 with abnormal
PI(3,4,5)P3 (PIP3) are indicated. The presented data are from at leastpatterning and extensive overgrowth of the cephalic and
three independent experiments. Error bars represent standard errorcaudal regions. At E7.5 and more dramatically at E8.5,
of the mean.
BrdU incorporation is increased in mPTEN3-5 mutants. (C) PTEN dephosphorylates PI(3,4,5)P3 in vitro. PI(3,4,5)P3 was incu-
In the head, proliferation is enhanced in the neuroepi- bated with 0.5 mg of purified wild-type PTEN protein (Trx-PTEN) or
thelium of the cephalic neural folds and in the underlying catalytically inactive mutant of PTEN (Trx-PTENC.S) as indicated,
extracted, and resolved by ascending thin-layer chromatography.mesenchyme. Increased proliferation in mPTEN3-5 em-
Positions of the origin and PI(3,4,5)P3 (PIP3) are indicated.bryos is consistent with the ability of ectopic PTEN to
suppress cell growth (Furnari et al., 1997, Cheney et
al., 1998). Nuclear integrity dye staining of mPTEN3-5
embryos does not reveal any alterations in apoptosis discrepancy between the phenotypes of mPTEN3-5 em-
bryos and cells could be explained by the fact that pro-associated with the mPTEN loss. In contrast, mPTEN-
deficient fibroblasts display no increase in proliferation gramed cell death during early embryogenesis is a rare
event (Coucovanis and Martin, 1995), preventing, usingbut decreased sensitivity to apoptosis. This apparent
PTEN in Negative Regulation of PKB/Akt
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the available methods, the detection of a potential de- be interesting to utilize our mPTEN-deficient cells to
further characterize the interaction between FAK andcrease in apoptosis in mPTEN3-5 embryos. Hence, hy-
perproliferation in mPTEN3-5 embryos could be a con- PTEN in vivo.
sequence of a differentiation defect associated with
decreased apoptosis due to mPTEN deficiency. In PI(3,4,5)P3 Is a Physiological Substrate of PTEN
support of such a view, immunostaining of wild-type The intact PI39K activity in mPTEN2/2 cells and the ability
mouse embryos demonstrated that tissue distribution of wortmannin to sensitize mPTEN2/2 cells to agonist-
of mPTEN coincides with regions where differentiation induced apoptosis suggested that the mechanism of
occurs (data not shown). Alternatively, immortalized em- mPTEN action might be at the level of the products of
bryonic fibroblasts derived from mPTEN3-5 embryos PI39K activity. The evidence presented here shows that
might not be analogous to the affected cells involved mPTEN negatively regulates the intracellular levels of
in the overgrowth in the mPTEN3-5 embryo and therefore PIP(3,4,5)P3, most likely via direct dephosphorylation,
might not display an equivalent proliferation defect. resulting in decreased phosphorylation and activity of
PKB/Akt. Consistent with our findings, a recent report
(Maehama and Dixon, 1998) has shown that PTEN isRole of PTEN in Apoptosis
capable of dephosphorylating PI(3,4,5)P3 in vitro andLoss of mPTEN in immortalized mouse embryonic fibro-
down-regulating its levels in insulin-stimulated 293 cells.blasts results in decreased sensitivity to cell death in
Taken together, our results establish PI(3,4,5)P3 dephos-response to diverse apoptotic stimuli. The effect of
phorylation as a major mechanism of PTEN action. Thus,mPTEN loss on apoptosis appears to be pleiotropic
in the absence of mPTEN, elevated levels of PI(3,4,5)P3considering that mPTEN2/2 cells no longer die in re-
result in increased PKB/Akt phosphorylation. Con-sponse to a number of treatments known to affect a
versely, expression of mPTEN negatively regulates PKB/variety of different signaling pathways. Such a broad
Akt phosphorylation/activity via dephosphorylation ofrole of mPTEN in regulation of cell survival suggests
PIP(3,4,5)P3.that mPTEN functions in a general pathway that regu-
lates cell death and survival. The evidence presented
here identifies a crucial regulator of cell survival, PKB/ The Role of PTEN in Tumorigenesis
PTEN mutations have been identified in a large numberAkt, as a major target of mPTEN activity. mPTEN regu-
lates phosphorylation and activity of PKB/Akt in cells. of different tumors, indicating that PTEN regulates fun-
damental cellular processes. Our results provide evi-Furthermore, expression of a constitutively active mu-
tant of PKB/Akt rescues cells from PTEN-induced apo- dence for such a critical role of PTEN in control of normal
cell growth. In certain tumors, loss of PTEN may resultptosis. Activation of PKB/Akt has been implicated in
protection from apoptosis in response to several growth in decreased sensitivity of mutant cells to apoptotic
stimuli. In other tumors, mutations of PTEN may lead tofactors and cytokines, including IGF-1 (Kulik et al., 1997),
IL-2 (Ahmed et al., 1997), and NGF (Ulrich et al., 1998). an increase in proliferative potential. Both survival and
proliferative advantages of PTEN-deficient cells wouldMoreover, elevated PKB/Akt activity protects cells from
apoptosis induced by withdrawal of survival signals promote cellular overgrowth and tumorigenesis.
PTEN mutations in humans have initially been identi-(reviewed in Downward, 1998), c-myc overexpression
(Kauffmann-Zeh et al., 1997), UV irradiation (Kulik et fied in glioblastomas (Li et al., 1997). Frequent amplifica-
tion of platelet-derived growth factor receptor (PDGFR)al., 1997), CD95/Fas-induced cell killing (Hausler et al.,
1998), and matrix detachment (Khwaja et al., 1997). De- and epidermal growth factor receptor (EGFR) genes
have also been demonstrated in glioblastoma (Chaffanetcreased sensitivity of mPTEN mutant cells to apoptosis
in response to TNFa, sorbitol, and anisomycin suggests et al., 1992; Smits and Funa, 1998). Furthermore, the
production and cellular response to fibroblast growththat active PKB/Akt also protects cells from death in-
duced by these agents. factor (FGF) are often elevated in astrocytomas and glio-
mas (Takahashi et al., 1992). PI39K is regulated by theActivation of SAPK/JNK, whose function in induction
and protection from apoptosis remains controversial activity of receptor-tyrosine kinases and is potentially
up-regulated in cells overexpressing PDGFR and EGFR,(Kyriakis and Avruch, 1996; Nishina et al., 1997), was
normal in our cells in response to UV irradiation, aniso- as well as in cells exposed to higher than normal levels
of FGF. Hypothetically, this would result in increasedmycin, and sorbitol (data not shown), indicating that this
pathway is not affected by the loss of mPTEN. Further- levels of intracellular PI(3,4,5)P3 and elevated activity of
PKB/Akt, giving the cells a survival advantage. The abil-more, TNFa stimulation of all three cell lines resulted in
a comparable level of phosphorylation of IkB (data not ity of PKB/Akt to protect cerebral neurons from apopto-
sis supports such a scenario (Dudek et al., 1997). More-shown), suggesting that NF-kB activation in our mutant
cells was intact and is therefore an unlikely cause of over, increased expression of PDGFR and EGFR, or
FGF overproduction in glioblastoma, could result in in-their altered cell death. A recent report (Tamura et al.,
1998) has identified direct interaction between focal ad- creased proliferation. Thus, other genetic alterations in
glioblastoma leading to PI39K activation might have sim-hesion kinase (FAK) and PTEN and demonstrated a role
of PTEN in regulation of cell migration and spreading. ilar phenotypic consequences on tumor development
as the loss of PTEN function.Even though our preliminary evidence does not reveal
any differences in matrix attachment between mPTEN1/2 v-akt, an oncogenic form of PKB/Akt resulting in in-
creased kinase activity, causes mouse T cell lymphomaand 2/2 cells (V. S., unpublished observations), it will
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oligonucleotide primer pairs specific for mouse b2-microglobulin(AKR) (Staal and Hartley, 1988; Bellacosa et al., 1991).
(sense primer 59-ATGGCTCGCTCGGTGACCCTAG-39; antisenseInterestingly, mice heterozygous for mPTEN frequently
primer 59-TCATGATGCTTGATCACATGTCTCG-39) or mouse fibro-develop T cell lymphomas that are associated with the
blast-specific protein-1 (sense primer 59-CAGCGAAAGAGGGTGAC
loss of heterozygosity at the mPTEN locus (A. S. et al., AAGTTCA-39; antisense primer 59-ATGTGCGAAGAAGCCAGAGTA
submitted). These tumors exhibit elevated phosphoryla- AGG-39) were used to amplify 1 mg of total RNA employing the
Titan one-tube RT-PCR system as per manufacturer's instructionstion of PKB/Akt in comparison to normal tissue, consis-
(Boehringer Mannheim/Roche). Reaction products were resolvedtent with our findings that PTEN negatively regulates
by 6% polyacrylamide gel electrophoresis and detected by ethidiumPKB/Akt signaling. In humans, overexpression of PKB/
bromide staining.Akt has been demonstrated in 15% ovarian (Cheng et
al., 1992), 12% of pancreatic (Cheng et al., 1996), and 3% Cloning, Expression, and Purification of mPTEN
of breast cancers (Bellacosa et al., 1995). Significantly, in A cDNA encoding the entire mouse PTEN open reading frame
addition to mutations shown in other tumors, LOH in was amplified from mouse brain mRNA by RT-PCR as above
using sense primer 59-GGATCCGACATGACAGCCATCATCAAAG 239the human PTEN locus has been observed in ovarian,
and antisense primer 59-CTCGAGTCAGACTTTTGTAATTTGTGAATGpancreatic, and breast tumor specimens (Teng et al.,
CTG-39, sequenced, and subcloned in-frame with two N-terminal1997). Such correlation in the rate of LOH of PTEN and
influenza virus hemagglutinin (HA) epitopes into the eukaryotic ex-
up-regulation of PKB/Akt in human cancer, together pression vector pcDNA3.1 (Invitrogen). An EcoRI-XhoI fragment
with the evidence presented here, emphasizes the im- from the resultant pcDNA3.1HA2mPTEN vector, encoding N-termi-
portance of PTEN/PKB/Akt interaction in tumor pro- nally HA-tagged mPTEN open reading frame, was ligated into the
EcoRI-SalI sites of the retroviral vector pBabeMN-z (a kind gift ofgression.
Dr. Garry Nolan). Full-length mPTEN cDNA and a fragment encodingOur results suggest that PTEN belongs to a class
a C-terminal portion of mPTEN (amino acids 151±403 of SwissProtof ªgatekeeperº tumor suppressor genes together with
O08586) were separately cloned into the thioredoxin-hexahistidine
p53, Rb, and APC. These genes participate in regulation tag (Trx) fusion vector pET32a (Novagen) and transfected into E.
of normal cell growth, and their mutations directly con- coli strain BL21(DE3)pLysS or BL21(DE3), respectively (Stratagene,
tribute to the neoplastic growth of the cell (Kinzler and La Jolla, CA).
Expression of Trx-mPTEN and Trx-mPTEN(151±403) fusion pro-Vogelstein, 1998). We propose that negative regulation
teins was induced in bacterial cultures at an OD600nm of 0.8 by theof PI39K/PKB/Akt cell survival signaling pathway is a
incubation in the presence of 0.8 mM isopropyl-b-D-thiogalactopy-likely mechanism by which PTEN exerts its tumor sup-
ranoside (IPTG) for 4 hr at 378C or 6 hr at 288C, respectively. Cells
pressor function. Thus, loss of PTEN results in general were lysed by sonication in lysis buffer (20 mM Tris-HCl [pH 8.0],
alteration of the normal cell homeostasis due to in- 100 mM NaCl, 20 mM imidazole, 10% glycerol, 5 mM b-mercaptoeth-
creased survival potential, which could subsequently anol, 0.5% Nonidet P-40, and protease inhibitors), cell lysate was
clarified by centrifugation, and supernatents passed through nickel-lead to tumorigenesis. Further investigations, including
nitrilotriacetic acid resin (Qiagen, Valencia, CA). Resin was washedthose aimed at elucidating modes of PTEN regulation,
with lysis buffer, and hexahistidine-tagged fusion protein was elutedwill provide valuable insight into the processes of cell
using an imidazole concentration gradient. Eluted Trx-mPTEN(151±
transformation and tumorigenesis. 403) protein was dialysed against storage buffer (50 mM Tris-HCl
[pH 8.0], 2 mM EDTA, 2 mM DTT, 150 mM NaCl) and concentrated
Experimental Procedures by ultrafiltration.
Eluted Trx-mPTEN fusion protein was dialysed against ion-
BrdU Labeling of Mouse Embryos exchange column equilibration buffer (25 mM Tris-HCl [pH 8.0], 2
Generation of mPTEN3-5 mutant embryonic stem cells and mice will mM EDTA, and 2 mM DTT) and passed through a Q-Sepharose FF
be described elsewhere. BrdU labeling of cells in the S phase of ion exchange column (Pharmacia Biotech, Inc.) equilibrated in the
the cell cycle was performed according to the protocol described same buffer. The column was washed with 10 column bed volume
by Hayashi et al. (1988). BrdU (100 mg/g of body weight) was injected of equilibration buffer, and Trx-mPTEN protein was eluted using 20
intraperitoneally into pregnant females at E7.5 and E8.5 of gestation. column bed volume of a 0±500 mM NaCl concentration gradient.
Females were sacrificed 1 hr after injection, the uteri removed, and The Trx-mPTEN containing fractions were pooled, dialysed against
complete deciduas or embryos fixed in 4% paraformaldehyde at storage buffer (25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA,
48C overnight and processed for immunohistochemistry. The sec- 1 mM DTT), and concentrated by ultrafiltration.
tions were incubated with an anti-BrdU monoclonal antibody (Boeh-
ringer Mannheim) at a 1:10 dilution. Staining was performed ac- Generation of Anti-PTEN Antibody
cording to the protocol described by Mishina et al. (1995). Rabbit antisera was raised against purified Trx-mPTEN(151±403)
protein (Antibodies, Inc., Davis, CA) and purified by preadsorption
Establishment of Immortalized Embryonic Fibroblast on Trx-coupled CNBr-Sepharose 4B followed by affinity purification
Cell Lines on GST-PTEN fusion protein coupled to CNBr-Sepharose 4B. Low-
Day 8.5 heterozygous and homozygous mPTEN3-5 embryos (A. S. et affinity antibody was eluted in a pH 5.0 buffer, and high-affinity,
al., submitted) were dissected, minced well by scissors, and cultured PTEN-specific antibody (used in this paper) was eluted off the affinity
individually in gelatinized 24-well plates containing Dulbecco modi- column with 0.1 M glycine (pH 2.5).
fied Eagle's medium (DMEM), 10% fetal calf serum (FCS), L-gluta-
mine, and b-mercaptoethanol. After 7 days of culture, cells were Cell Lysis
trypsinized, replated, incubated for 1 hr, and washed three times For the generation of cytoplasmic cell lysates, cells were washed
with PBS to remove nonadherent cells. Adherent cells were continu- in ice-cold PBS and lysed by incubation on ice in a buffer containing
ously cultured for 3 months using the 3T3 protocol (Goldman, 1998). 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10% glycerol, 1% Triton
Embryo genotyping was performed by PCR with DNA from the yolk X-100, 50 mM NaF, 100 mM sodium vanadate, 1 mM benzamidine,
sac, using specific primer sets to detect wild-type and the mutant and 5 mg/ml leupeptin. The lysates were centrifuged and superna-
mPTEN allele, respectively. tants analyzed.
For the generation of whole-cell lysates, the tissues were homoge-
nized in a buffer containing 10 mM Tris-HCl (pH 7.4), 1 mM MgCl2,RT-PCR
Total RNA was prepared from 5 3 106 cells using TRIZOL reagent as 1 mM EGTA, 0.5 mM CHAPS, 10% glycerol, 50 mM NaF, 100 mM
sodium vanadate, 1 mM benzamidine, and 5 mg/ml leupeptin andper manufacturer's protocols (Life Technologies). Intron-spanning
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incubated on ice for 30 min. The lysates were centrifuged and super- critical reading of the manuscript; and Miki Sato for her support.
J. R. is supported by a fellowship from the Deutsche Forschungs-natants analyzed.
gemeinschaft.
Western Blot Analysis
Proteins were resolved by 12.5% SDS-PAGE, electroblotted to PVDF
Received July 8, 1998; revised August 14, 1998.membrane (Boehringer Manheim), blocked in 4% skim milk, 13 PBS,
0.05% Tween-20, and probed with primary antibodies. Anti-PTEN
is described above; anti-phosphoS473 PKB/Akt and anti-PKB/Akt
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